BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4307060)

  • 1. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective properties of theta-hemolysin obtained by affinity chromatography].
    Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxin production by Cl. perfringens of types A and D on synthetic media].
    Bychenko BD; Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):84-9. PubMed ID: 4298565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Akhundova KA; Vlasova EV; Il'nitskaia KA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):134-6. PubMed ID: 176848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of experimental Clostridium novyi and Cl. perfringens gas gangrene in high-velocity missile wounds by active immunisation.
    Boyd NA; Thomson RO; Walker PD
    J Med Microbiol; 1972 Nov; 5(4):467-72. PubMed ID: 4345766
    [No Abstract]   [Full Text] [Related]  

  • 9. [The experimental validation of methods for the emergency immunoprophylaxis of gas gangrene].
    Sergeeva TI; Chirikova EV; Babaĭtseva VA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):9-13. PubMed ID: 8525744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental gas gangrene with food-poisoning Clostridium perfringens type A.
    Hauschild AH; Thatcher FS
    Can J Microbiol; 1968 Jun; 14(6):705-9. PubMed ID: 4298928
    [No Abstract]   [Full Text] [Related]  

  • 11. [An electron microscopic study of Cl. perfringens in the process of toxin formation].
    Kushnarev VM; Smirnova TA; Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):19-24. PubMed ID: 4308710
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative study of the antigenic and immunogenic properties of the anatoxin of Cl. perfringens, concentrated and purified by various methods].
    Larina IA; Samsonova VS; Volkova ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Apr; 45(4):86-9. PubMed ID: 4309741
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 14. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
    Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of Cl. perfringens types A, B, C, D, E and F in the etiology of gas gangrene].
    Marasanova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):116-21. PubMed ID: 4329186
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of zinc on the production of various toxins of Clostridium perfringens.
    Murata R; Soda S; Yamamoto A; Sato H; Ito A
    Jpn J Med Sci Biol; 1969 Jun; 22(3):133-48. PubMed ID: 4310348
    [No Abstract]   [Full Text] [Related]  

  • 18. [Method of determinating the protective capacity of C1. perfringens toxoid].
    Akhundova KA; Nenashev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):43-7. PubMed ID: 176851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
    Vlasova EV; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphologic and some histochemical changes in the organism of immune guinea pigs during intramuscular injection of Cl. sordelli toxin].
    Ermakova MP; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Apr; 48(4):105-9. PubMed ID: 5561295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.